Literature DB >> 16469745

Activating transcription factor 3, a stress-inducible gene, suppresses Ras-stimulated tumorigenesis.

Dan Lu1, Curt D Wolfgang, Tsonwin Hai.   

Abstract

ATF3 is a stress-inducible gene that encodes a member of the ATF/CREB family of transcription factors. Current literature indicates that ATF3 affects cell death and cell cycle progression. However, controversies exist, because it has been demonstrated to be a negative or positive regulator of these processes. We sought to study the roles of ATF3 in both cell death and cell cycle regulation in the same cell type using mouse fibroblasts. We show that ATF3 promotes apoptosis and cell cycle arrest. Fibroblasts deficient in ATF3 (ATF3(-/-)) were partially protected from UV-induced apoptosis, and fibroblasts ectopically expressing ATF3(-/-) under the tet-off system exhibited features characteristic of apoptosis upon ATF3 induction. Furthermore, ATF3(-/-) fibroblasts transitioned from G(2) to S phase more efficiently than the ATF3(+/+) fibroblasts, suggesting a growth arrest role of ATF3. Consistent with the growth arrest and pro-apoptotic roles of ATF3, ATF3(-) fibroblasts upon Ras transformation exhibited higher growth rate, produced more colonies in soft agar, and formed larger tumor upon xenograft injection than the ATF3(+/+) counterparts. ATF3(-/-) cells, either with or without Ras transformation, had increased Rb phosphorylation and higher levels of various cyclins. Significantly, ATF3 bound to the cyclin D1 promoter as shown by chromatin immunoprecipitation (ChIP) assay and repressed its transcription by a transcription assay. Taken together, our results indicate that ATF3 promotes cell death and cell arrest, and suppresses Ras-mediated tumorigenesis. Potential explanations for the controversy about the roles of ATF3 in cell cycle and cell death are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469745     DOI: 10.1074/jbc.M509278200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  103 in total

1.  Activation of the c-Jun N-terminal kinase/activating transcription factor 3 (ATF3) pathway characterizes effective arylated diazeniumdiolate-based nitric oxide-releasing anticancer prodrugs.

Authors:  Anna E Maciag; Rahul S Nandurdikar; Sam Y Hong; Harinath Chakrapani; Bhalchandra Diwan; Nicole L Morris; Paul J Shami; Yih-Horng Shiao; Lucy M Anderson; Larry K Keefer; Joseph E Saavedra
Journal:  J Med Chem       Date:  2011-10-28       Impact factor: 7.446

2.  Activating transcription factor 3 promotes colon cancer metastasis.

Authors:  Zhi-Yong Wu; Zheng-Mao Wei; Sheng-Jie Sun; Jing Yuan; Shun-Chang Jiao
Journal:  Tumour Biol       Date:  2014-05-24

3.  ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types.

Authors:  Anderly C Chüeh; Janson W T Tse; Michael Dickinson; Paul Ioannidis; Laura Jenkins; Lars Togel; BeeShin Tan; Ian Luk; Mercedes Davalos-Salas; Rebecca Nightingale; Matthew R Thompson; Bryan R G Williams; Guillaume Lessene; Erinna F Lee; Walter D Fairlie; Amardeep S Dhillon; John M Mariadason
Journal:  Clin Cancer Res       Date:  2017-06-13       Impact factor: 12.531

4.  Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors.

Authors:  Kyungsil Yoon; Syng-Ook Lee; Sung-Dae Cho; Kyounghyun Kim; Shaheen Khan; Stephen Safe
Journal:  Carcinogenesis       Date:  2011-03-01       Impact factor: 4.944

5.  Deficiency of Atf3, an adaptive-response gene, protects islets and ameliorates inflammation in a syngeneic mouse transplantation model.

Authors:  E J Zmuda; M Viapiano; S T Grey; G Hadley; A Garcia-Ocaña; T Hai
Journal:  Diabetologia       Date:  2010-03-28       Impact factor: 10.122

6.  Activated Transcription Factor 3 in Association with Histone Deacetylase 6 Negatively Regulates MicroRNA 199a2 Transcription by Chromatin Remodeling and Reduces Endothelin-1 Expression.

Authors:  Chen Li; Yu Zhou; Anastacia Loberg; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Mol Cell Biol       Date:  2016-10-28       Impact factor: 4.272

7.  Tat-induced FOXO3a is a key mediator of apoptosis in HIV-1-infected human CD4+ T lymphocytes.

Authors:  Alicja Dabrowska; Nayoung Kim; Anna Aldovini
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

8.  The ubiquitously expressed bZIP inhibitor, JDP2, suppresses the transcription of its homologue immediate early gene counterpart, ATF3.

Authors:  Keren Weidenfeld-Baranboim; Tal Hasin; Ilona Darlyuk; Ronit Heinrich; Ofer Elhanani; Jianzhi Pan; Kazunari K Yokoyama; Ami Aronheim
Journal:  Nucleic Acids Res       Date:  2009-02-20       Impact factor: 16.971

9.  Activation of alternative Jdp2 promoters and functional protein isoforms in T-cell lymphomas by retroviral insertion mutagenesis.

Authors:  Mads Heilskov Rasmussen; Bruce Wang; Matthias Wabl; Anders Lade Nielsen; Finn Skou Pedersen
Journal:  Nucleic Acids Res       Date:  2009-06-05       Impact factor: 16.971

10.  Dramatic co-activation of WWOX/WOX1 with CREB and NF-kappaB in delayed loss of small dorsal root ganglion neurons upon sciatic nerve transection in rats.

Authors:  Meng-Yen Li; Feng-Jie Lai; Li-Jin Hsu; Chen-Peng Lo; Ching-Li Cheng; Sing-Ru Lin; Ming-Hui Lee; Jean-Yun Chang; Dudekula Subhan; Ming-Shu Tsai; Chun-I Sze; Subbiah Pugazhenthi; Nan-Shan Chang; Shur-Tzu Chen
Journal:  PLoS One       Date:  2009-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.